Workshop Partner
Studylog (Company bio - Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.
Expertise Partner
LIDE Biotech is a Shanghai-based, AAALAC award winning oncology contract research provider with 12 years of delivering drug evaluation services to 200+ clients worldwide. We offer preclinical CRO services like pharmacology, PK and biomarker studies with 70+ CDX models and 1900 PDX models. Our library covers 50+ cancer types and 200+ pretreated models that harbor special naturally-occurred drug resistance and/or genetic alterations. We also have proprietary tools offering in-vivo drug validation in 7-10 days.
Program Partner
TD2 Translational Drug Development
We are your scientifically driven and flexible partner for drug development. Our team is fully dedicated to oncology – it is al we do – combining innovation and expertise to quickly move your therapies from preclinical development into clinical trials. Adaptive and forward-thinking – we guide your therapy through the most critical development milestones from the lab to planning your regulatory and clinical strategy and ultimately approved.
Program Partner
Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology. Our product is “Oncology Intelligence™”—highly predictive therapeutic response data derived from advanced biological models of cancer. Our proprietary platform informs individual treatment decisions and accelerates the development of new cancer therapies. We partner with therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Through more clinically relevant, well-characterized and annotated models, advanced imaging technology and thoughtfully designed studies, Certis brings greater certainty to go/no-go development decisions.
Program Partner
Kiyatec is a functional precision oncology company that accurately measures the response of each patient’s live cancer cells to aid in drug development and inform clinical treatment decisions. The company works in partnership with leading biopharmaceutical companies to unlock response dynamics for their pre-clinical investigational drug candidates across most solid tumor types. Kiyatec’s CLIA- certified labs offer clinical testing for high-grade glioma, and is developing assays for use in ovarian, breast, NSCLC, and rare tumors.
Exhibition Partner
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development lifecycle. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patientderived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
You can give us a call on (+1) 617 455 4188, email sponsor@hansonwade.com.
We endeavor to respond within 48 hours of receiving your message.